[ad_1]
![](https://images.newscientist.com/wp-content/uploads/2023/08/07103442/SEI_166421125.jpg?width=1200)
An illustration of amyloid plaques on a nerve cell
Sebastian Kaulitzki / Alamy
A blood check that signifies if somebody is at excessive threat of creating Alzheimer’s illness went on sale to the general public within the US on 31 July. It might give individuals an early warning about their deteriorating well being, maybe permitting them to take preventative measures, says the producer, Quest Diagnostics. However some medical doctors are urging warning, saying the science continues to be too unsure and a constructive outcome might trigger individuals nice misery for no actual profit.
The check is predicated …
[ad_2]
Source link